Search company, investor...

Compare CardioDx vs Osprey Medical

Customers evaluate the quality of CardioDx's products using the following success metrics.

Overview

CardioDx Logo

CardioDx is 21 yrs old and is based in United States.

CardioDx is a cardiovascular genomic diagnostics company located in Redwood City, California. The company is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, cardiac arrhythmia, and heart failure, CardioDx is poised to expand patient access and improve healthcare quality and efficiency through the commercialization of genomic technologies. CardioDx performs the Corus CAD test in its onsite clinical laboratory which has been certified by the Centers for Medicare and Medicaid Services (CMS) according to the Clinical Laboratory Improvements Amendments (CLIA) and is accredited by the College of American Pathologists (CAP). The CardioDx laboratory is licensed to perform tests for all 50 states.

Osprey Medical Logo

Osprey Medical is 19 yrs old and is based in United States.

Osprey Medical is a medical device company focused on the development and commercialization of its CINCOR System designed for the prevention of Contrast Induced Nephropathy (CIN). The CINCOR System originated from technology developed at the Baker Heart and Diabetes Institute in Melbourne, Australia. Osprey Medical's technologies are designed to reduce the amount of dye (contrast) injected during commonly performed heart procedures to protect the kidneys from damage known as contrast induced nephropathy (CIN). Dye is routinely used to x-ray the heart during angioplasty and stenting procedures. Patients at high risk of CIN often have pre-existing chronic kidney disease. Prevention of CIN in high risk patients may lead to shorter hospital stays, improved patient outcomes, and may ultimately save patients' lives.

Founded Year

Country

United States
United States

Demo Video

Demo not available because CardioDx has not claimed their profile.

Work for CardioDx? Show off your product.

Demo not available because Osprey Medical has not claimed their profile.

Work for Osprey Medical? Show off your product.

Leadership

Khushro F Mehta (Chief Executive Officer, President)

See all 5 people

Michael McCormick (Chief Executive Officer, President)

See all 2 people

Funding

Osprey Medical last raised $1.5M on 4/16/2020.

Total Raised

Investors

Silicon Valley Bank, Solar Capital

See all 5 investors

Paycheck Protection Program, CM Capital

See all 4 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because CardioDx has not claimed their profile.

Work for CardioDx? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for CardioDx?

Claim your profile now.

Information not available because Osprey Medical has not claimed their profile.

Work for Osprey Medical? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Osprey Medical?

Claim your profile now.

Expert Collections

D

Digital Health

10,565 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

D

Digital Health

10,565 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.